Trial · NCT03030599
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Weekly Number of Cataplexy Attacks | JZP-258 | 0.00 | Inter-Quartile Range -0.49 to 1.75 | attacks | |
| Change in Weekly Number of Cataplexy Attacks | Placebo | 2.35 | Inter-Quartile Range 0.00 to 11.61 | attacks | |
| Change in the Epworth Sleepiness Scale (ESS) Score | JZP-258 | 0.00 | Inter-Quartile Range -1.0 to 1.0 | score on a scale | |
| Change in the Epworth Sleepiness Scale (ESS) Score | Placebo | 2.0 | Inter-Quartile Range 0.00 to 5.0 | score on a scale | |
| Number of Participants With Worsening Patient Global Impression of Change (PGIc) for Narcolepsy Overall | JZP-258 | 3 | Participants | ||
| Number of Participants With Worsening Patient Global Impression of Change (PGIc) for Narcolepsy Overall | Placebo | 29 | Participants | ||
| Number of Participants With Worsening Clinical Global Impression of Change (CGIc) for Narcolepsy Overall | JZP-258 | 4 | Participants | ||
| Number of Participants With Worsening Clinical Global Impression of Change (CGIc) for Narcolepsy Overall | Placebo | 39 | Participants | ||
| Change in 36-Item Short Form Health Survey Version 2 (SF-36v2) Scores | JZP-258 | Physical Component Summary | -0.03 | Inter-Quartile Range -2.07 to 2.41 | score on a scale |
| Change in 36-Item Short Form Health Survey Version 2 (SF-36v2) Scores | Placebo | Physical Component Summary | -1.92 | Inter-Quartile Range -3.46 to 1.73 | score on a scale |
| Change in 36-Item Short Form Health Survey Version 2 (SF-36v2) Scores | JZP-258 | Mental Component Summary | 1.55 | Inter-Quartile Range -1.88 to 3.78 | score on a scale |
| Change in 36-Item Short Form Health Survey Version 2 (SF-36v2) Scores | Placebo | Mental Component Summary | -1.92 | Inter-Quartile Range -6.28 to 1.34 | score on a scale |
| Change in 5-level EQ-5D (EQ-5D-5L) Crosswalk Index Score and Visual Analog Scale | JZP-258 | Crosswalk index | 0.00 | Inter-Quartile Range -0.01 to 0.03 | score on a scale |
| Change in 5-level EQ-5D (EQ-5D-5L) Crosswalk Index Score and Visual Analog Scale | Placebo | Crosswalk index | 0.00 | Inter-Quartile Range -0.05 to 0.03 | score on a scale |
| Change in 5-level EQ-5D (EQ-5D-5L) Crosswalk Index Score and Visual Analog Scale | JZP-258 | VAS Score | 0.00 | Inter-Quartile Range 0.00 to 5.00 | score on a scale |
| Change in 5-level EQ-5D (EQ-5D-5L) Crosswalk Index Score and Visual Analog Scale | Placebo | VAS Score | -5.00 | Inter-Quartile Range -10.00 to 5.00 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03030599/results